The Financial Supervision Commission (FSC) registered the shares issued by Tchaikapharma High Quality Medicines Inc. as a result of an increase of the company’s capital with a view to trading on a regulated securities market. This is evident from the regulator’s decisions at the meeting held on the 23rd of August.

The equity issue amounts to 7 700 000 ordinary, dematerialized voting shares with a nominal value of BGN 1 each.

You can read the entire article here.